Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05325294 · ClinicalTrials.gov registry record · NA
Evaluation of the Advanced Hybrid Closed Loop (AHCL) System in Type 1 Adults and Pediatrics Utilizing Lyumjev®
A NA study, sponsored by Medtronic MiniMed.
- Completed
- Registry status
- NA
- Development phase
- 244
- Enrollment target
NCT05325294: Completed NA study, sponsored by Medtronic MiniMed.
NCT05325294 is a NA study that has completed, run by Medtronic MiniMed. The registered enrollment target is 244 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05325294, a NA study, has completed, sponsored by Medtronic MiniMed.
- COMPLETED
- Registry status
- NA
- Development phase
- 244 participants
- Enrollment target
Study Summary
This US study will evaluate the safety and effectiveness of utilizing insulin Lyumjev® lispro-aabc in the MiniMed™ 780G System in Type 1 adult and pediatric subjects in a home setting to support product and system labeling.
Interventions
- DEVICE MiniMed 780G System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 244 participants |
| Start Date | 2022-05-05 |
| Est. Completion | 2024-01-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05325294
The ClinicalTrials.gov registry entry for NCT05325294 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 244 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic MiniMed, which has 29 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MiniMed 780G System is the first listed.
NCT05325294 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05325294 about?
NCT05325294 is a clinical study titled "Evaluation of the Advanced Hybrid Closed Loop (AHCL) System in Type 1 Adults and Pediatrics Utilizing Lyumjev®". This US study will evaluate the safety and effectiveness of utilizing insulin Lyumjev® lispro-aabc in the MiniMed™ 780G System in Type 1 adult and pediatric subjects in a home setting to support product and system labeling.
What is the current status of trial NCT05325294?
This trial is currently completed. It is a NA study. The enrollment target is 244 participants. The study started on 2022-05-05. Estimated completion is 2024-01-03.
What interventions are being tested in trial NCT05325294?
The interventions under investigation include: MiniMed 780G System (DEVICE).
Who is sponsoring clinical trial NCT05325294?
This trial is sponsored by Medtronic MiniMed, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.